pcloudyn.png
Wednesday April 1st, 2020 3:18AM

Potential coronavirus treatment granted rare disease status

By The Associated Press
Related Articles
  Contact Editor

WASHINGTON (AP) — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales.

What that specialty status will actually mean for the marketing or profitability of Gilead Science's experimental drug remdesivir isn't clear. The drugmaker did not immediately respond Tuesday to requests for comment.

Experts who have studied the so-called “orphan drug” program say the company's request — and the Food and Drug Administration's decision to grant it — seem inappropriate given the rapidly expanding threat of the viral outbreak.

A financial analyst, though, called Gilead's request “pretty standard.”

The FDA granted the status on Monday, according to the agency's website. If approved for coronavirus, Gilead Sciences would receive seven years of exclusive U.S. marketing for the drug and tax credits on its research and development costs.

Congress created the orphan drug program more than 35 years ago to encourage companies to develop drugs for niche diseases and conditions that might not otherwise be profitable. But since then, filing for orphan status has become a standard pharmaceutical industry tactic to extend the profitability of drugs and block competitors. Orphan drugs are also typically eligible for other special programs that speed up FDA reviews for approval.

The FDA defines a rare disease as one with fewer than 200,000 patients in the U.S. In a statement Tuesday, the agency said COVID-19 fit that criteria when the request was made. There are more than 50,000 cases in U.S. but many more expected in the coming weeks and months.

“It seems like a misuse of the Orphan Drug Act, even though technically it’s within the bounds of the law,” said Dr. Aaron Kesselheim, a Harvard Medical School health policy expert. “There’s no expectation here that this drug wouldn’t be able to generate appropriate revenue for the manufacturer.”

Kesselheim said a number of the early AIDS drugs also received orphan drug status in the 1980s and 1990s, but then went on to generate billions in sales.

But Tyler Van Buren, a senior research analyst at the financial services firm Piper Sandler, called Gilead's filing “pretty standard.”

“It says nothing about profiting off of the pandemic, but it does provide protection if remdesivir turns into a business in subsequent years," he said.

In recent years the orphan drug program has come under scrutiny from the media, Congress and government inspectors amid concerns that it is being misused to protect six-figure prices on specialty drugs. Roughly half of the 48 new drugs approved by the agency last year received orphan drug designation. Many were priced well above $100,000 for a year's supply, including drugs for cancer, muscular dystrophy and other genetic disorders.

The nonprofit Public Citizen group said in a statement that the U.S. government should be “urgently concerned” with the affordability of remdesivir.

Gilead's chairman and CEO, Daniel O'Day has previously said the company hasn’t discussed with any governments how much remdesivir will cost.

“The topic of pricing comes up once you know the medicine works,” he said.

Remdesivir, given through an IV, is being tested in at least five separate experiments, and Gilead also has provided it to several hundred severely ill COVID-19 patients in the U.S, Europe and Japan under "compassionate use" provisions. The company said Sunday it was halting that program due to an unmanageable number of requests.

The drug interferes with virus reproduction and has shown some promise in lab and animal studies against other coronaviruses that cause similar diseases, MERS and SARS. It was also used briefly in some Ebola patients in Congo.

For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The vast majority of people recover.

Day said earlier this month at a press conference with other drug industry executives that his company has been working on the drug's development for a decade. He said Gilead has spent “really billions of dollars” developing the drug and plans to spend even more to scale up manufacturing facilities at Gilead and its partners.

Gilead didn’t respond to questions seeking more details about the company’s spending on remdesivir, including whether the figures used by O’Day included the U.S. government money spent on research by federal scientists and grants to universities.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: U.S. News, Associated Press (AP), AP National News, AP Online National News, Top U.S. News short headlines, Top General short headlines, AP Online Headlines - Washington, AP Online Congress News, AP Health, AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2020 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
The Latest: US Olympic track trials to be rescheduled
The U.S. Olympic track and field trials in Eugene, Oregon, will be rescheduled in the wake of the International Olympic Committee’s decision to postpone the 2020 Tokyo Games because of the spread of the coronavirus
4:04PM ( 7 minutes ago )
The Latest: 1st person in US detention tests positive
A 31-year-old from Mexico has become the first person in immigration detention in the U.S. to test positive for COVID-19
4:03PM ( 7 minutes ago )
Potential coronavirus treatment granted rare disease status
The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators
3:59PM ( 11 minutes ago )
Associated Press (AP)
Trump says he hopes US will be reopened by Easter amid virus
President Donald Trump is weighing how to refine nationwide social-distancing guidelines to put some workers back on the job amid the coronavirus outbreak
2:57PM ( 1 hour ago )
US deal may be at hand to ease economic pain of coronavirus
A deal may be at hand to ease the economic pain of the coronavirus pandemic in the U.S. Both Senate Majority Leader Mitch McConnell and the top Democrat, Sen. Chuck Schumer, say agreement appears close
2:43PM ( 1 hour ago )
Trump hopes country will be reopened by Easter amid outbreak
President Donald Trump is weighing how to refine nationwide social-distancing guidelines to put some workers back on the job amid the coronavirus outbreak
2:03PM ( 2 hours ago )
AP Online Headlines - Washington
The Latest: NY Gov. Cuomo: Infection rate accelerating
New York Gov. Andrew Cuomo sounded his most dire warning yet about the coronavirus pandemic, saying the infection rate in New York is accelerating
12:00PM ( 4 hours ago )
Stocks surge over 7% on building hopes for US virus stimulus
Stocks are jumping in midday trading on Wall Street Tuesday amid expectations that Congress is nearing a deal on a big coronavirus relief bill
11:57AM ( 4 hours ago )
Georgia cities group urges all to impose virus restrictions
The Georgia Municipal Association is urging all 538 cities in the state to impose a nighttime curfew and other restrictions to slow the coronavirus outbreak
11:35AM ( 4 hours ago )
AP Online Congress News
The Latest: Italy raises fines for lock down violators
With Italy on an uphill course to contain the world’s second-largest outbreak of the coronavirus, Premier Giuseppe Conte has announced much stiffer fines for violators of the national lock-down restrictions
3:35PM ( 36 minutes ago )
Business Fallout: US manufacturing pivot; drinking at home
Manufacturers are reconfiguring operations to help produce desperately needed medical gear
3:14PM ( 57 minutes ago )
The Latest: 3 US sailors on aircraft carrier test positive
Acting Navy Secretary Thomas Modly says three sailors aboard the USS Theodore Roosevelt have tested positive for coronavirus
3:05PM ( 1 hour ago )
AP Business
New US Soccer leadership: Settling women's lawsuit priority
The new president and chief executive officer of the U.S. Soccer Federation say settling a lawsuit filed by women's national team players is a priority
1:48PM ( 2 hours ago )
Iconic plant's end spells doom for struggling coal industry
A coal plant in western Kentucky has shut down, marking a defeat for coal, President Trump and other top politicians who tried to keep it open
1:21PM ( 2 hours ago )
US manufacturing might vs virus; drinking at home
Manufacturers are reconfiguring operations to help produce desperately needed medical gear
1:03PM ( 3 hours ago )
AP Business - Corporate News
Can blood from coronavirus survivors treat the newly ill?
Hospitals are gearing up to test if a century-old treatment used to fight off pre-vaccine epidemics of flu, measles and other infections might work for COVID-19, too — using blood donated from patients who've recovered
11:20AM ( 4 hours ago )
Egypt announces 2-week nightly curfew to slow virus
Egypt has announced a two-week, 7 p.m. to 6 a.m. curfew for its over 100 million people to slow the spread of the new coronavirus
10:34AM ( 5 hours ago )
Stocks up over 5% amid building hopes for US virus stimulus
Stocks are jumping in early trading on Wall Street Tuesday amid expectations that Congress is nearing a deal on a big coronavirus relief bill
9:50AM ( 6 hours ago )
AP Business - Industries
War-torn Syria braces for lockdown after first virus case
Syrians are rushing to stock up on food and fuel amid fears that authorities will resort to even stricter measures after reporting the first coronavirus infection in the country
1:42PM ( 1 day ago )
The Latest: WHO director warns virus spread accelerating
The head of the World Health Organization says the coronavirus outbreak is accelerating
12:33PM ( 1 day ago )
The Latest: Stadium in São Paulo to be turned into hospital
Pacaembu Stadium in São Paulo is being turned into an open-air hospital to help fight the coronavirus outbreak
12:11PM ( 1 day ago )
AP Business - Health Care
Tokyo Olympics postponed, U.S. closes in on relief package
The International Olympic Committee has postponed this summer's Tokyo Games for a year as coronavirus deaths mount around the world and U.S. lawmakers close in on a nearly $2 trillion deal to help cushion the economic damage from the crisis
3:57PM ( 14 minutes ago )
With isolation, abuse activists fear an 'explosive cocktail'
As families across the country and the globe hunker down at home, there's another danger, also insidious if less immediately obvious, that worries advocates and officials: A potential spike in domestic violence, as victims spend day and night trapped at home with their abusers, with tensions rising, nowhere to escape, limited or no access to friends or relatives _ and no idea when it will end
3:51PM ( 20 minutes ago )
Dow surges 10% as Congress moves closer to passing virus aid
Stocks are surging on Wall Street Tuesday, sending the Dow industrials up 10%, as Congress nears a deal to inject $2 trillion into the economy to mitigate damage from the coronavirus outbreak
3:48PM ( 24 minutes ago )
Trump hoping to see US economy reopened by Easter amid virus
President Donald Trump is weighing how to refine nationwide social-distancing guidelines to put some workers back on the job even as as the nation copes with the coronavirus pandemic
3:46PM ( 25 minutes ago )
'A bullet train': Virus peak may come soon, swamp hospitals
Gov. Andrew Cuomo has sounded his most dire warning yet about the coronavirus pandemic
3:46PM ( 26 minutes ago )